Maxcyte (MXCT) EBT Margin (2020 - 2026)
Maxcyte's (MXCT) quarterly EBT Margin came in at 122.05% in Q2 2026, up 2321.0% year-over-year from 5.04% in Q2 2025, and down 147.97% quarter-over-quarter from 49.22% in Q1 2026.
Powered by 
Analysis
Maxcyte (MXCT) EBT Margin (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported EBT Margin for 7 consecutive years, with 122.05% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin rose 2321.0% year-over-year to 122.05% in Q2 2026; TTM through Jun 2026 was 114.77%, a 1046.0% increase from a year earlier, with the FY2025 full-year figure at 135.14%, down 2885.0% from the prior year.
- EBT Margin was 122.05% for Q2 2026 at Maxcyte, down from 49.22% in the prior quarter.
- Over five years, EBT Margin peaked at 33.69% in Q4 2023 and troughed at 181.81% in Q3 2025.
- A 5-year average of 100.2% and a median of 107.5% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 7430 bps in 2022 and sank 9179 bps in 2023, its largest moves.
- Over 5 years, EBT Margin stood at 38.71% in 2022, then grew by 13 bps to 33.69% in 2023, then sank by 262 bps to 121.9% in 2024, then retreated by 8 bps to 131.45% in 2025, then gained by 7 bps to 122.05% in 2026.
- The last three EBT Margin figures came in at 122.05% (Q2 2026), 49.22% (Q1 2026), and 131.45% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.12 Bn | 221.06 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 144.34 Bn | 139.99 Bn | 3.61 Bn | 17.21% |
| 3 | Agilent Technologies | 41.01 Bn | 39.25 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 31.14 Bn | 29.97 Bn | 770.00 Mn | 22.43% |
| 5 | Revvity | 13.89 Bn | 12.86 Bn | 416.87 Mn | 8.71% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 22.01% |
| 7 | Bio-Rad Laboratories | 10.13 Bn | 8.51 Bn | 345.80 Mn | 83.27% |
| 8 | Repligen | 9.34 Bn | 8.33 Bn | 110.04 Mn | 6.93% |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn | -12.34% |
| 10 | Maxcyte | 132.99 Mn | 132.99 Mn | 5.60 Mn | -122.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -122.05% |
| Mar 31, 2026 | -49.22% |
| Dec 31, 2025 | -131.45% |
| Sep 30, 2025 | -181.81% |
| Jun 30, 2025 | -145.26% |
| Mar 31, 2025 | -98.76% |
| Dec 31, 2024 | -121.90% |
| Sep 30, 2024 | -141.56% |
| Jun 30, 2024 | -89.89% |
| Mar 31, 2024 | -83.99% |
| Dec 31, 2023 | -33.69% |
| Sep 30, 2023 | -140.57% |
| Jun 30, 2023 | -116.24% |
| Mar 31, 2023 | -126.89% |
| Dec 31, 2022 | -38.71% |
| Sep 30, 2022 | -60.45% |
| Jun 30, 2022 | -85.97% |
| Mar 31, 2022 | -35.10% |
| Dec 31, 2021 | -48.01% |
| Sep 30, 2021 | -26.44% |